SCHEMBL4898748

SCHEMBL4898748

Clc1ccc(Nc2cccc(-c3ccc(Cl)cn3)n2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.50
KDR P35968 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
XBP1 P17861 1/20 0.44
AHR P35869 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.41
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4891120 0.88 SLC2A1 (0.62) SLC2A1KDRSMN1; SMN2MEN1KMT2A
SCHEMBL4902638 0.88 SLC2A1 (0.42) SLC2A1KDRNPC1RAB9ATNNI3K
SCHEMBL4892301 0.86 SLC2A1 (0.44) SLC2A1KDRSMN1; SMN2MEN1KMT2A
SCHEMBL4903020 0.84 SLC2A1 (0.51) SLC2A1KDRSMN1; SMN2MEN1KMT2A
SCHEMBL4901584 0.84 SLC2A1 (0.48) SLC2A1KDRSMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL4896691 0.83 SLC2A1 (0.47) SLC2A1KDRSMN1; SMN2MEN1KMT2A
SCHEMBL4901286 0.82 CCND3 (0.48) EGFR
SCHEMBL5311907 0.81 SLC2A1 (0.40) SLC2A1KDRSMN1; SMN2MEN1KMT2A
SCHEMBL2226110 0.80 SLC2A1 (0.44) SLC2A1KDRSMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL4901183 0.80 SLC2A1 (0.39) SLC2A1KDRSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 SLC2A1 2369/4885KDR 3367/4885SMN1; SMN2 3670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.